A Whole-Genome Screen of a Quantitative Trait of Age-Related Maculopathy in Sibships from the Beaver Dam Eye Study  by Schick, James H. et al.
Am. J. Hum. Genet. 72:1412–1424, 2003
1412
A Whole-Genome Screen of a Quantitative Trait of Age-Related
Maculopathy in Sibships from the Beaver Dam Eye Study
James H. Schick,1 Sudha K. Iyengar,1 Barbara E. Klein,2 Ronald Klein,2 Karlie Reading,1
Rachel Liptak,1 Christopher Millard,1 Kristine E. Lee,2 Sandra C. Tomany,2 Emily L. Moore,2
Bonnie A. Fijal,2 and Robert C. Elston1
1Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland; and 2Department of Ophthalmology and Visual
Sciences, University of Wisconsin Medical School, Madison
Age-related maculopathy (ARM) is a leading cause of visual impairment among the elderly in Western populations.
To identify ARM-susceptibility loci, we genotyped a subset of subjects from the Beaver Dam (WI) Eye Study and
performed a model-free genomewide linkage analysis for markers linked to a quantitative measure of ARM. We
initially genotyped 345 autosomal markers in 325 individuals ( sib pairs) from 102 pedigrees. Ten regionsNp 263
suggestive of linkage with ARM were observed on chromosomes 3, 5, 6, 12, 15, and 16. Prior to fine mapping,
the most significant regions were an 18-cM region on chromosome 12, near D12S1300 ( ); a region onPp .0159
chromosome 3, near D3S1763, with a P value of .0062; and a 6-cM region on chromosome 16, near D16S769,
with a P value of .0086. After expanding our analysis to include 25 additional fine-mapping markers, we found
that a 14-cM region on chromosome 12, near D12S346 (located at 106.89 cM), showed the strongest indication
of linkage, with a P value of .004. Three other regions, on chromosomes 5, 6, and 15, that were nominally
significant at are also appropriate for fine mapping.P  .01
Introduction
Age-related maculopathy (ARM) is an important cause
of severe visual impairment (R. Klein et al. 1995; Tielsch
1995). Although the natural history of ARM is becoming
better understood, its pathogenesis remains unknown
(Schick et al. 2001). Data from most family studies of
ARM have suggested a strong genetic component (Mey-
ers and Zachary 1988; Dosso and Bovet 1992; Small et
al. 1992, 1999; Stone et al. 1992; Meyers 1994; Meyers
et al. 1995; Hoyng et al. 1996; M. L. Klein et al. 1998;
Weeks et al. 2000).
ARM is typically characterized by the presence of
large, soft, yellow-white drusen. Such drusen may be
distributed either individually or in close proximity to
adjacent drusen. These drusen usually first appear in
the 5th decade of life and become more pronounced
with age (R. Klein et al. 1997). Progression of the dis-
ease is marked by disruption of cells in the outer layer
of the retina, characterized by the appearance of gray-
ish-blackish deposits in the deep retina, accompanied
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by depigmentation of the retinal pigment epithelium
(RPE), and may take on several different forms. One
form of late ARM, known as “geographic atrophy”
or “dry” ARM, is usually characterized by a sharply
defined, round area of drop out of the outer segments
of the retinal rod and cone photoreceptors and the
RPE. Another form, labeled as “neovascular” or “wet”
ARM, involves the new growth of small choroidal
blood vessels into the subretinal space.
Data from several population-based studies have
provided information on the prevalence, incidence,
and rates of progression of ARM (Kahn et al. 1977a,
1977b; B. E. Klein and R. Klein 1982; Gibson et al.
1985; Bressler et al. 1989, 1995; B. E. Klein et al. 1990;
R. Klein et al. 1992, 1997, 1999a, 1999b; Mitchell et
al. 1995; Schachat et al. 1995; Vingerling et al. 1995;
Cruickshanks et al. 1997; Sparrow et al. 1997). One
such study was conducted in a large (Np 4,926), most-
ly (99%) white population of persons 43–86 years of
age living in Beaver Dam, WI (R. Klein et al. 1992,
1997). In Beaver Dam, persons 75 years of age had
a prevalence of late ARM of 7.1% and a 5-year inci-
dence of 5.4% (R. Klein et al. 1992, 1997). Heiba et
al. (1994) performed a complex segregation analysis
of the sibships identified in this population, using Bon-
ney’s (1984) class D regressive model. They found a
quantitative measure for ARM based on the Wisconsin
Age-Related Maculopathy Grading Scheme protocol
(R. Klein and B. E. K. Klein 1991; R. Klein et al. 1991a,
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1991b, 1991c, 1992) and adjusted for age- and age2-
suggested evidence of major gene segregation. The re-
sults were consistent with a majorMendelian gene effect
contributing ∼55% and ∼57% of the total variability
in the right and left eyes, respectively. Following up this
evidence, we performed a genomewide screen in a sam-
ple of 105 sibships from this population, to identify loci
segregating for ARM. In the present article, we describe
a model-free linkage analysis of these sibship data.
Families and Methods
Families
The Beaver Dam Eye Study (BDES) comprises a com-
munity sample of 4,926 subjects between 43 and 86 years
of age who are of mostly western European extraction
(R. Klein et al. 1992, 1997). Beaver Dam was selected
for a study of maculopathy because it had a high partici-
pation rate in a previous population-based study of di-
abetic retinopathy and because it had a relatively stable
population ( at the time of the 1980 census)Np 17,179
(R. Klein et al. 1991c). Eligibility requirements for entry
into the study included living in the city or township of
Beaver Dam and being in the target age range at the
time of a private census performed in 1987–88. Of 6,612
households identified, 3,715 contained at least one per-
son who satisfied the age criterion. Of 5,924 persons who
were eligible for participation, we examined 4,926 per-
sons over a 30-mo period, 337 permitted an interview
only, 226 died before the examination, 39 moved out of
the area, 18 could not be located, and 378 refused to
participate. Family relationships were ascertained during
the study evaluation, and pedigrees were constructed. Of
the 4,926 observations at baseline examination, 2,783
were distributed among 602 pedigrees. Severity scores for
ARM that were based on the Wisconsin Age-Related
MaculopathyGrading Scheme (R. Klein andB. E.K.Klein
1991; R. Klein et al. 1991a, 1991b, 1991c, 1992; Heiba
et al. 1994) were assigned for the right and left eye of
each participant. There were 105 sibships selected for
genotyping and linkage analysis. These sibships had to
contain one member who had a mean severity score, for
the two eyes, of4.5. This criterion was chosen because,
on the basis of the prior segregation analysis (Heiba et
al. 1994), such individuals would have only a 2.5% prob-
ability of not having two copies of a putative recessive
severity-increasing allele. In addition, the samplewas aug-
mented by sibships that had been selected, on the basis
of severity, for nuclear sclerosis and cortical cataracts.The
genotyped data set contains 325 individuals. The sibships
range in size from two to six, with an average of 2.46
persons per sibship. Similar to the original data set, the
subset contains slightly more females ( ) thanNp 176
males ( ). Those genotyped comprise a total ofNp 149
263 sib pairs from 105 sibships representing 102 ped-
igrees.
Phenotypic Evaluation
Although earlier clinical studies of ARMrelied ondirect
and indirect ophthalmoscopy for the detection of this con-
dition, later studies found that stereoscopic color fundus
photographs of the macula provide a more objective, sen-
sitive, and reproducible method for the documentation of
ARM (R. Klein and B. E. K. Klein 1991; R. Klein et al.
1991a, 1991b, 1991c; Bird et al. 1995). The photographs
are graded using standardized protocols to detect and
classify the presence and severity of ARM lesions. Details
of the grading procedure have been described elsewhere
(R. Klein et al. 1991a, 1991b). In brief, a circular grid
was placed on the photographic slide, dividing the mac-
ular area into nine subfields, consisting of central (a single
subfield), inner (four inner subfields), and outer (four out-
er subfields) circles. Some lesions were graded in each sub-
field, other lesions were graded only in the subfield defin-
ing the macular area, and still others were graded in ad-
ditional fields outside the macular area. For the purpose
of the present article, only measurements made within the
nine subfields defined by the grid are presented. Circles
of defined size (63, 125, 175, 250, 322, 350, and 644 mm
in diameter) that were printed on clear plastic were used
to estimate the size of drusen and areas involved by dru-
sen, increased retinal pigment, and RPE depigmentation.
Two gradings were performed for each eye (R. Klein
and B. E. K. Klein 1991, 1995; R. Klein et al. 1991a,
1991b; 1992, 1997, 2001, 2002). First, a preliminary
masked grading was done by one of two senior grad-
ers. Second, detailed gradings were performed by one
of three other experienced graders. For detailed grad-
ing, each eye was graded independently of the fellow
eye. The assessment consisted of a subfield-by-subfield,
lesion-by-lesion evaluation of each photograph set, us-
ing the Wisconsin Age-Related Maculopathy Grading
Scheme (R. Klein et al. 1991a, 1991b). After both grad-
ings were performed, a series of edits and reviews were
performed. The presence and severity of specific lesions
at the third examination (e.g., maximum drusen size,
type, area, and pigmentary abnormalities), as deter-
mined by detailed grading, were compared to those of
the preliminary grading. Standardized edit rules were
used to adjudicate disagreements (R. Klein et al. 1991a,
1997). Finally, the detailed graders were asked to make
side-by-side comparisons between baseline, 5-year fol-
low-up, and 10-year follow-up photographs for eyes
that showed change in ARM lesions between baseline
and follow-up. These edits were masked as to whether
the photographs were taken at baseline or follow-up.
A 15-level severity scale based on pigmentary abnor-
malities, geographic atrophy, signs of exudative macular
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Table 1
Revised Wisconsin Age-Related Maculopathy Coding Protocol
Level
Drusen Diameter
(mm) Drusen Typea
Drusen Area
(mm2)
Increased Retinal Pigment
(mm) RPE Depigmentation Late ARM
1 None/questionable None/HI None None None None
2 !63 HD !9,160 None None None
3 !63 HD 9,160 None None None
4 63 HD/SD !196,350 None None None
5 !63 HD Any size Any size None None
!63 HD Any size None Any size None
!63 HD Any size Any size Any size None
6 63 HD/SD 196,350 None None None
63 HD/SD !196,350 !125 None None
7 63 HD/SD 196,350 !125 None None
63 HD/SD !196,350 125 in 1 subfields
or !125 in 2 subfields
None None
63 SI/Ret !196,350 None or !125 None None
8 63 HD/SD 196,350 125 in 1 subfields
or !125 in 2 subfields
None None
63 HD/SD !196,350 None or any size !6.25% None
63 SI/Ret 196,350 None or !125 None None
63 SI/Ret !196,350 125 in 1 subfields
or !125 in 2 subfields
None None
9 63 HD/SD 196,350 None or any size !6.25% None
63 HD/SD !196,350 None or any size 6.25% of 1 subfields
or !6.25% of 2 subfields
None
63 SI/Ret 196,350 125 in 1 subfields
or !125 in 2 subfields
None None
63 SI/Ret !196,350 None or any size !6.25% of subfield None
10 63 HD/SD 196,350 None or any size 6.25% of 1 subfields
or !6.25% of 2 subfields
None
63 SI/Ret 196,350 None or any size !6.25% of subfield None
63 SI/Ret !196,350 None or any size 6.25% of 1 subfields
or !6.25% of 2 subfields
None
11 63 SI/Ret 196,350 None or any size 6.25% of 1 subfields
or !6.25% of 2 subfields
None
12 NA NA NA NA NA Geographic atrophyb
13 NA NA NA NA NA Exudative, detachmentc
14 NA NA NA NA NA Exudative, advancedc
15 NA NA NA NA NA Geographic atrophy,
exudative
Data given represent maximum allowable in any gradable subfield. NA p not applicable.
a HI p hard indistinct; HD p hard distinct; SD p soft distinct; SI p soft indistinct; Ret p reticular.
b In the absence of exudative ARM.
c In the absence of geographic atrophy.
degeneration, and drusen size, type, and area was con-
structed (table 1). The ordering of the scale was based
on associations of the presence and absence of early signs
of ARM with the incidence of progression to geographic
atrophy or exudative macular degeneration (R. Klein
and B. E. K. Klein 1995).
ARM severity was determined on each eye at three
time points spaced at 5-year intervals, and, at each time
point, the scores for the right and left eyes were aver-
aged. However, if a score was missing for either eye,
then the score for the available eye was substituted for
the missing score (this occurred for 7.9% of the persons
in the study). Then, because the scores for at least two
time points were available for all of the persons in the
linkage-analysis data set, the scores at two time points
were averaged to produce the final score. When scores
at all three time points were available, which occurred
for 74.46% of the participants, the first and last scores
were averaged; otherwise, the scores at the two avail-
able time points were averaged. In this way, all of the
scores in the analysis were based on the same or a
similar amount of information. We then used multiple
regression analysis to investigate the effects of age, age2,
and sex—together with their interactions—as well as to
investigate the effects that alcohol consumption, smok-
ing and multiple-vitamin usage (as represented by cat-
egorical variables), and sunlight exposure had on this
ARM score. As has previously been observed by Heiba
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et al. (1994), who used the Wisconsin Age-RelatedMac-
ulopathy Grading Scheme (R. Klein and B. E. K. Klein
1991; R. Klein et al. 1991a, 1991b, 1991c), we found
age and age2 to be nominally significant in predicting
maculopathy, assuming independence among persons,
and the residuals were used as our trait value—that is,
ARMresidualp [(ARMfirst examination ARMlast examination)/2]
8.6124  (0.2269 # age)  (0.0023 # age2).
Molecular Methods
Genome scan.—We genotyped 345 markers from 22
autosomal chromosomes by using the Weber panel 8
marker set, which has an average marker spacing of
11 cM. We also genotyped two additional markers,
D1S406 and D1S236, contained in a 14-cM candidate-
gene region spanning the ABCR (retina-specific ABC
transporter) gene, which is suggested to be the gene re-
sponsible for Stargardt disease, a recessive macular dys-
trophy that has been considered to be related to ARM
(Allikmets et al. 1997). Another four markers—D1S466,
D1S202, D1S2625, and D1S413—in a 26-cM candi-
date-gene region, on 1q21-q35, that is postulated to con-
tain an autosomal dominant locus related to a dry type
of ARM (M. L. Klein et al. 1998) were also genotyped.
Thus, 351 markers were initially genotyped.
After extracting DNA from the blood samples, we
used a fluorescence-based genotyping method for the
genome scan. PCR primers conjugated with fluores-
cent dyes were purchased from IDT Technology and
Applied Biosystems. Genomic DNA (at 10 ng/ml, 3 mls)
was PCR amplified using 0.225 U of Platinum Taq
DNA Polymerase (Gibco), Tris-HCl (200 mM, pH 8.4),
dNTPs (200 mM each), MgCl2 (1.0–3.0 mM), and for-
ward and reverse PCR primers (0.2 mM). The final
reaction volume was 12 ml, and the reactions were
performed in 96-well plates on an MJ Research Tetrad
DNA Engine. The amplification reactions were opti-
mized for the fluorescent-dye–labeled primers by us-
ing the published conditions as the initial value. After
PCR, 8–10 markers were pooled to create multiplexed
panels. Each panel was size separated on an ABI 377
(Applied Biosystems) DNA Sequencer running the Gene-
Scan 3.1 software for Macintosh. Tamra 500 size stan-
dards were run in each lane, and the data were collect-
ed and analyzed using the Genotyper 2.5 software. Be-
sides the in-lane standards, each 96-well plate contained
four CEPH controls (two samples each from individuals
1331–01 and 1331–02). The CEPH controls were used
to standardize allele calling across plates, with the rep-
licates being the safeguard for allele-calling reliability.
Fine mapping.—After reviewing the first-stage ge-
nome-scan linkage results, we extended our coverage
of chromosome 12 to include an additional 25 mark-
ers over an area of suggestive significance that over-
lapped a region previously reported to show linkage
with ARM (Weeks et al. 2000). Our fine-mapped re-
gion of interest on chromosome 12 has an average spac-
ing density of 2.2 cM. We also decided to fine map areas
of suggestive significance indicated by our genome scan,
on chromosome 3, 5, and 16. We extended our coverage
to include an additional 8 markers on chromosome 3,
in two candidate-gene areas (one in a 16.48-cM region
between D3S1304 and D3S3038 and the other in a
29.45-cM region between D3S1764 and D3S3053);
10 markers on chromosome 5, in an 88.10-cM region
between D5S1457 and D5S1480; and four markers
on chromosome 16, in a 46.33-cM region between
D16S764 (18.51 cM) and D16S753.
Genotyping protocols for fine mapping were similar to
those for the genome scan. Multiplexed panels of mark-
ers were size separated on an ABI 3700 (Applied Biosys-
tems) capillary gel by running the GeneScan 3.5 software
for Windows NT. Rox 500 size standards were run in
each lane, and the data were collected and analyzed us-
ing the Genotyper 3.6 software for Windows NT. Initial
marker placements were based on locations provided at
the Marshfield Center for Medical Genetics Web site, al-
though other placements were also investigated.
Error Checking
After each round of genotyping, the allelic data were
checked for Mendelian inconsistencies, using the pro-
gram Markerinfo (S.A.G.E., version 4.2). Family mem-
bers whose data were inconsistent withMendelian trans-
mission were referred back to the laboratory for verifica-
tion. We also compared the observed number of homo-
zygotes to the expected number of homozygotes based
on the estimated allele frequencies and Hardy-Weinberg
equilibrium proportions. A significant inequality between
the observed and expected numbers of homozygotes could
indicate that some heterozygotes were miscalled as ho-
mozygotes (Gomes et al. 1999). However, we found no
significant departure from Hardy-Weinberg proportions
in our data. After regenotyping and final verification, alle-
lic inconsistencies that could not be reconciled (0.68%)
were changed to missing values for the purpose of anal-
ysis. Consistent estimates of allele frequencies for each
genetic marker were then established by gene counting.
Prior to performing the linkage analysis, we reclas-
sified the sib pairs in each pedigree according to their
likely true relationship, using the program Reltest
(S.A.G.E., version 4.2). Reltest makes use of a Mar-
kov-process model of allele sharing along the chro-
mosomes, to classify relationships (Olson 1999). The
probability of misclassification depends on the total
length of the genome scan and overall marker infor-
mativeness. It is possible for individual pairs to be
misclassified if one or both members have a high pro-
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Figure 1 Multipoint results of the genomewide linkage scan for ARM in the BDES linkage analysis, using the Weber panel 8 map spacing.
For each chromosome (Chr), genetic distance (cM) and log10(P) value (pP) are plotted on the X- and Y-axes, respectively. Horizontal lines
are drawn at and .Pp .05 Pp .01
portion of missing genotypes. We reclassified 6 indi-
viduals in 3 full sibships as unrelated and 21 individ-
uals in 12 full sibships as half-sibs. There was only
one reclassification in which both members of a sib
pair had as much as 10% missing data.
Linkage Analysis
It is known that the power of a model-free quantitative-
trait linkage analysis depends on the scale ofmeasurement
(Wilson et al. 1991). To perform a Box-Cox power trans-
formation of the data (Box andCox 1964),which requires
that all themeasures be positive, we adjusted the quantita-
tive scores to 80 years old, as done by Heiba et al. (1994).
We repeated the segregation analysis performed by Heiba
et al. (1994) on these new adjusted scores, specifically in
the subsample that was genotyped, and we obtained re-
sults similar to those originally reported (data not shown),
finding that the most parsimonious model was the two
mean, recessive model, although the estimated allele fre-
quency for high values was larger, also expected because
of the ascertainment bias. In particular, a Box-Cox power
transformation parameter gave the best indi-l p 0.7591
cation of genetic involvement under the recessive model.
Thus, the age-adjusted scores were raised to this power
prior to linkage analysis.
We used Sibpal (S.A.G.E., version 4.2), a model-free
linkage program, to perform a multipoint linkage anal-
ysis. The reported P values were obtained assuming the
usual asymptotic distribution of the likelihood-ratio test
statistics, but all critical results were verified by a per-
mutation test: the estimates of allele sharing were per-
muted among sibships of the same size, as well as within
sibships in the case of sibships with more than two sibs.
A weighted average, of the squared trait difference
and the squared mean-corrected trait sum, that is fur-
ther adjusted for the nonindependence of the sib pairs
(Elston and Shete 2000; Shete et al., in press) was used
as the dependent variable to perform the linear regres-
sions (option W4 in Sibpal). In this method, the optimal
weights are inversely proportional to the residual vari-
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Table 2
Multipoint Estimates and P Values on Chromosomes
3, 5, 6, 12, 15, and 16, Showing Possible Linkage
( ) with ARM in the BDES Genome ScanP  .05
Location
(cM) Marker P
Chromosome 3:
24.0 .0368
26.0 GATA164B08 .0323
28.0 .0269
30.0 .0237
32.0 .0234
34.0 .0267
36.0 .0338
38.0 D3S1259 .0444
40.0 .0460
172.0 .0486
174.0 .0318
175.0 D3S1744 .0272
176.0 .0209
178.0 .0121
180.0 .0077
182.0 .0062
184.0 .0066
186.0 D3S1763 .0081
188.0 .0109
190.0 .0169
192.0 .0289
Chromosome 5:
68.0 .0474
70.0 .0392
72.0 .0371
74.0 D5S2500 .0382
76.0 .0398
78.0 .0419
80.0 .0450
82.0 .0495
Chromosome 6:
84.0 .0439
86.0 D6S1031 .0415
88.0 .0444
152.0 .0390
154.0 .0306
156.0 GATA165G02 .0286
158.0 .0218
160.0 .0192
162.0 .0213
164.0 .0289
166.0 .0429
Chromosome 12:
94.0 .0497
96.0 .0296
98.0 .0192
99.0 D12S1300 .0159
100.0 .0165
102.0 .0185
104.0 .0222
106.0 .0278
108.0 PAH .0354
(continued)
Table 2 (continued)
Location
(cM) Marker P
Chromosome 15:
30.0 D15S659 .0477
32.0 .0463
34.0 .0413
36.0 .0422
92.0 D15S816 .0444
Chromosome 16:
36.0 .0413
38.0 .0130
39.0 D16S769 .0086
40.0 .0113
42.0 .0242
108.0 .0360
110.0 .0273
112.0 .0241
114.0 .0257
116.0 .0308
117.0 D16S539 .0344
118.0 .0319
120.0 .0290
122.0 .0291
124.0 D16S621 .0317
ances that are obtained from two different regressions,
based respectively on the squared sib-pair trait differ-
ences and the mean-corrected trait sums. Control of
the type I error probabilities is achieved by using a
generalized-estimating-equation approach with a ro-
bust sandwich estimate of the variance (Huber 1967;
Gourieroux et al. 1984). Although this method is very
efficient (Putter et al. 2002), it can become numerically
unstable and require caution when the residual corre-
lations among the squared sib-pair trait differences and
the squared mean-corrected sib-pair trait sums become
large. In these linkage analyses, we did not observe any
numerical instability.
Results
Genome Scan
The results of the whole-genome scan are presented in
figure 1. We observed 14 markers on six chromosomes
(3, 5, 6, 12, 15, and 16), with a significance level of
(table 2). Two possible regions of linkage, con-P  .05
taining four markers altogether, are located on chromo-
some 3, with D3S1763 having the greatest significance
( ). Our analysis suggests that D5S2500 (Pp .0081 Pp
)—on chromosome 5, in a region initially suggested.0382
by Weeks et al. (2000) but later lost when more sib pairs
were added (Weeks et al. 2001)—may be marginally sig-
nificant for linkage whereas two markers (D6S1031 and
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Figure 2 Fine-mapping multipoint results on chromosome 12
for the BDES linkage analysis, compared using the Weber panel 8,
Weizmann Institute Unified Database (UDB), and Harvard Partners
fine-mapping marker positions. Genetic distance (cM) and log10(P)
value (pP) are plotted on the X- and Y-axes, respectively.
Table 3
Multipoint Estimates and P Values on Chromosome
12, Showing Possible Linkage ( ) with ARMP  .05
in the BDES Genome Scan
Location
(cM) Marker P
102.00 .0206
103.20 D12S309 .0140
104.00 .0098
106.00 .0048
106.89 D12S346 .0040
107.00 D12S1671 .0064
107.00 D12S1300 .0063
107.32 D12S1588 .0067
108.00 .0066
109.06 D12S1727 .0088
110.00 .0095
112.00 .0139
113.19 PAH .0190
114.00 .0223
114.06 D12S360 .0229
114.71 D12S338 .0251
116.00 .0324
NOTE.—Marker positions were obtained using the
Harvard Partners fine map of chromosome 12. P val-
ues and distances between markers were interpolated
by S.A.G.E., version 4.2.
GATA165G02) on chromosome 6, each located in a dif-
ferent region of the chromosome, show slight significance.
We found suggestions of linkage to ARM at a P value
.05 over an 18-cM region, on chromosome 12, that
includes D12S1300 ( ) and PAH ( ),Pp .0159 Pp .0354
which are located within 20 cM of a previous linkage
report (Weeks et al. 2000). Chromosome 15 exhibitsmar-
ginal evidence of linkage to ARM in two regions located
62 cM apart, at D15S659 and D15S816, whereas chro-
mosome 16 suggests evidence of linkage at D16S769
( ), located at 39 cM, and at a second region,Pp .0086
located between 117 and 124 cM, that containsD16S539
and D16S621.
Fine Mapping on Chromosome 12
We fine mapped the area of significance on chromo-
some 12 indicated by our genome scan, because there
was significant overlap between this region and a pre-
vious report of ARM linkage (Weeks et al. 2000). We
extended our coverage to include an additional 25mark-
ers across a 54-cM region on 12q21-q24, according to
the marker locations provided at the Marshfield Center
for Medical Genetics Web site. A subsequent review of
the public databases led us to conclude that a consensus
fine map did not exist for chromosome 12, and the struc-
ture and size of our sibship sample was not sufficient
to independently derive map order. Thus, we conducted
linkage analyses using two additional map orders based
on physical maps provided at the Weizmann Institute
Unified Database for Human GenomeMappingWeb site
and the Harvard Partners Genome Center Web site, to
improve map order. Figure 2 shows a comparison of the
fine-mapping linkage results obtained by using each of
the three maps. Using the map positions provided by the
Harvard Partners map, we narrowed our region of sig-
nificance to a 14-cM area, on 12q22-q23, that contained
fivemarkers indicated to be significantly linkedwithARM
at (table 3). The peak marker in this region isPp .01
D12S346 ( ).Pp .004
Fine Mapping on Chromosomes 3, 5, and 16
After reviewing the results of our follow-up mapping
of chromosomes 3, 5, and 16 (fig. 3), we found that, in
contrast to our fine mapping of chromosome 12, the link-
age signals in our first candidate region, on chromosome
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Figure 3 Fine-mapping multipoint results on chromosomes 3,
5, and 16 for the BDES linkage analysis, using the Weber panel 8
marker placements. Genetic distance (cM) and log10(P) value (pP)
are plotted on the X- and Y-axes, respectively.
Table 4
Chromosome 1 Candidate-Gene Regions, Multipoint Estimates,
and P Values Associated with Each Marker
Marker Estimate  SE P
Allikmets et al. (1997) region:
D1S406 .1485  .2770 .2962
D1S236 .0368  .2794 .5523
M. L. Klein et al. (1998) region:
D1S466 .1052  .2544 .3399
D1S518 .0112  .2576 .5174
D1S202 .0739  .2555 .3864
D1S2625 .1468  .2354 .2667
D1S413 .2095  .2489 .2003
D1S1660 .0072  .2600 .5111
3, had weakened significantly whereas our signal in our
second candidate region had become marginal at best.
Our signal on chromosome 5 virtually disappeared, and,
on chromosome 16, the signal in our fine-mapped region
around D16S769 had diminished to the point of marginal
significance. We attempted to improve results for these
chromosomes by using alternativemarker placements,but
few differences were observed in the results.
Candidate-Gene Regions on Chromosome 1
We were also interested in the relationship between
ARM in the Beaver Dam study and the dry form of
ARM expressed by mutations in the recently discovered
ABCR gene (Allikmets et al. 1997). This gene was re-
fined to a 2-cM region located between the polymor-
phic markers D1S406 and D1S236, on 1p21-p13, in a
set of families with Stargardt disease. Although this
group has reported additional data in support of their
original findings (Allikmets et al. 2000), other studies
have given negative results (De La Paz et al. 1999;
Souied et al. 2000; Yates and Moore 2000). Further-
more, a candidate gene for a dry form of ARM has
been reported to be located within a 9-cM region on
1q25-q31, between D1S466 and D1S413, and to seg-
regate as an autosomal dominant trait (M. L. Klein et
al. 1998). Accordingly, we also fine mapped a 12-cM re-
gion that included D1S466, D1S518, D1S202, D1S2625,
D1S413, and D1S1660. Using theWeber panel 8 marker
locations, we found weak evidence with GATA129H04
( ) in our genomewide multipoint analysis to sup-Pp .07
port a hypothesis of linkage to ARM, but this marker
was 56.9 cM away from the ABCR gene and was neither
in the ABCR region (Allikmets et al. 1997) nor in the
region specified by M. L. Klein et al. (1998) (table 4).
To completely exclude these two regions, we performed
tests that allowed for both additive and dominant com-
ponents (Elston et al. 2000). Since the P values for all
these tests were !.5 in these regions, we cannot exclude
linkage. However, the evidence on 1p is weak at best
( ).P 1 .25
Discussion
We performed a whole-genome scan for ARM by using
a quantitative trait that is representative of the continu-
um of severity for macular degeneration—ranging from
drusen, which are an early characteristic of ARM and
other macular diseases (Stone et al. 1999; Tarttelin et
al. 2001), to late ARM (table 1). To map susceptibility
genes, we selected sibships for genotyping that would
have higher mean and variance of age-adjusted ARM
scores than the general BDES population, although we
did not select specifically for any particular form of
ARM, wet or dry. Prior to linkage analysis, we inves-
tigated the effects of covariates and found only age and
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age2 to be nominally significant in the prediction of mac-
ulopathy. We used a power-transformed ARM score af-
ter adjusting for age and age2 as the chosen ARM trait
for linkage analysis. Other correlates (e.g., smoking, sun-
light exposure, and vitamin use) have been reported to
be associated with ARM (Taylor et al. 1992). However,
these covariates are generally associated with the most
severe forms of the disease. Using the BDES population
data ( ), we did not observe any evidence thatNp 4,926
these variables play a role in the full disease spectrum
that included the less severe forms. Nevertheless, we per-
formed an additional linkage analysis that included co-
variates for drinking, smoking, sunlight exposure, and
vitamin use and found no found no significant differ-
ences in the results.
We genotyped an additional 25 markers in the region
of interest on chromosome 12. After the addition of these
markers, the linkage signal increased from a multipoint
P value of .0159, for D12S1300, when the marker order
in the Marshfield map for Weber panel 8 was used, to a
multipoint P value of .004, for D12S346, when themark-
ers were reordered using the chromosome 12 physical
map provided by the Harvard Partners (fig. 2). After
adding more samples and markers, Weeks et al. (2001)
obtainedweaker evidence for linkagewithARMon chro-
mosome 12, with an Sall score of 1.5. Although their
results are not inconsistent with ours, we also observed
that correct specification of the marker order during the
fine-mapping stage was very important. For example, if
either the Marshfield map or the Weizmann map were
utilized during the fine-mapping stage, we lost some of
the linkage signal (fig. 2). Although Weeks et al. (2001)
used Simwalk2 to identify excessive numbers of double
recombinants, they apparently did not investigate alter-
native map orders in the fine-mapping step, and this may
be one cause for a weaker linkage signal in the denser
scan. An alternative explanation is locus and phenotypic
heterogeneity between their sample and ours.
The phenotype that we describe in the present article
is not the same as that described in previous genome
scans for ARM (Weeks et al. 2000, 2001). Weeks et al.
(2000) collected a set of 364 families (2,129 individuals)
from vitreoretinal practices and utilized a dichotomous
trait, with a large percentage of affected individuals hav-
ing evidence of exudative disease, for their model-based
and model-free linkage analyses. With the most liberal
criteria that they used for affection status, Weeks et al.
(2000, 2001) would have classified only those individ-
uals with severity scores of12 on our scale as affected.
By using a quantitative trait and a power transforma-
tion, rather than a binary trait, we might expect to in-
crease power to detect linkage, becausewe no longer have
to classify each individual into one of two categories
(affected or unaffected) with the attendant probability
of misclassifying individuals into the wrong category
(Elston 1979).
Weeks et al. (2000) performed an affected-only analy-
sis. They computed LOD scores while assuming, a priori,
a single simple dominant model (disease-allele frequen-
cy 0.0001; p 0.01, p 0.90, and p 0.90, wheref f f0 1 2
is the penetrance for an individual with i susceptibili-fi
ty alleles), allowing for heterogeneity under an admix-
ture model. They used three different models to define
affection status. Their first model, A, classified as af-
fected only the population subset that included individ-
uals clearly affected with ARM as determined on the ba-
sis of drusen, pigmentary changes, and the presence of
end-stage disease; all others were classified as unknown.
In their second model, B, those individuals classified as
affected under model A were augmented by individuals
who were probably affected with ARM, with all others
again being classified as unknown. The third model, C,
adds to those affected individuals defined in model B
by also classifying as affected those individuals who
lacked sufficient evidence to rule out ARM, with all
others being classified as unknown. When the Gene-
Hunter Plus software package was used, model C dem-
onstrated possible linkage near D12S2070, in a region
on 12q21-q24, bounded by D12S1052 and D12S1045,
with a nonparametric LOD score of 1.43. This signal,
based on a larger number of affected persons in the
analysis, can be interpreted as detecting a locus that
may have any effect, moderate or severe. This area is
the same general area, on chromosome 12, that we
found to be linked to general ARM susceptibility in
the present study.
The approach of Weeks et al. (2000, 2001) was geared
toward identifying the most severe phenotype and is
therefore likely to lead to susceptibility loci for the most
severe forms of ARM. In contrast, our approach focuses
on the identification of susceptibility genes for the whole
range of disease, from mild to severe. Although not all
drusen progress to late ARM, soft, large drusen are
thought to represent the first stage in a multistep ARM
progression (R. Klein et al. 2002). Identification of loci
for inception or early stages of the disease is just as im-
portant as identification of genes for severe forms of the
disease. Using the chosen quantitative trait, we found
several chromosomal areas suggestive of linkage, includ-
ing regions on chromosomes 3, 5, 12, 15, and 16 (fig.
1). Our conclusion would be that any concordance in
linkage results for the most severe disease (model A;
Weeks et al. 2000, 2001), versus the full spectrum (pres-
ent analysis), would mean that we have replicated evi-
dence for loci that predispose to greater severity.
Weeks et al. (2000) also reported a region of interest
near D5S1480, on 5q32, where glutathione peroxidase
3 has been localized (Yoshimura et al. 1994); however,
this region is located at the opposite end of chromosome
Schick et al.: Multipoint Linkage Analysis of ARM 1421
Table 5
Candidate Genes Located Proximal and Distal to D12S346 ( ) after Fine MappingPp .004
Locus Gene Name
DSPG3 (MIM 601657) Dermatan sulphate proteoglycan 3
KERA (MIM 603288) Keratocan
LUM (MIM 600616) Lumican
DCN (MIM 125255) Decorin
BTG1 (MIM 109580) B-cell translocation gene
EEA1 (MIM 605070) Early endosome antigen 1
SOC2_Human Unknown
MRPL42 Unknown
UBE2N (MIM 603679) Ubiquitin-conjugating enzyme
PGAM1 (MIM 172250) Phosphoglyceric acid mutase
CRADD (MIM 603454) Casp2 and Ripk1 domain-containing adaptor with death domain
PLXNC1 (MIM 604259) Plexin C1
NR2C1 (MIM 601529) Nuclear receptor subfamily 2, group C, member 1
N7BM_Human Unknown
VEZA_Human Unknown
NTN4 Netrin 4
SNRPF (MIM 603541) Small nuclear ribonucleoprotein polypeptide F
HAL (MIM 235800) Histidinemia
LTA4H (MIM 151570) Leukotriene A4 hydroxylase
ELK3 (MIM 600247) ETS-domain protein
APAF1 (MIM 602233) Apoptotic protease activating factor 1
D12S346
NR1H4 (MIM 603826) Nuclear receptor subfamily 1, group H, member 4
ARL1 ADP-ribosylation factor-like 1
MYBPC1 (MIM 160794) Myosin-binding protein C, slow type
CHPT1 Unknown
AD16_Human Unknown
IGF1 (MIM 147440) Insulin-like growth factor 1
PAH (MIM 261600) Phenylalanine hydroxylase
ASCL1 (MIM 100790) Achaete-scute complex, Drosophila, homolog-like 1
TRA1 (MIM 191175) Tumor rejection antigen-1
TDG (MIM 601423) Thymine-DNA glycosylase
PGAM1 (MIM 172250) Phosphoglycerate mutase 1
NFYB (MIM 189904) Nuclear transcription factor Y, b
TXNRD1 (MIM 601112) Thioredoxin reductase 1
NOTE.—The given loci are located between 90.4 and 103.9 Mb on the chromosome 12 Ensembl
physical map.
5 from where our study suggests linkage, near D5S2500,
on 5p15. Our other linkage signals resided on regions
other than 1q31, 9p13, 10q26, and 17q25, whereWeeks
et al. (2001) obtained maximal evidence for linkage with
ARM. The result on 1q31, found in the interval between
D1S1660 and D1S1647 (Weeks et al. 2001), is consistent
with the ARM linkage originally reported byM. L. Klein
et al. (1998), with a LOD score of 2.46 in a large family.
In contrast, in the Beaver Dam sample, we found only
weak evidence at best to support a hypothesis of link-
age between ARM and either 1q25-q31, as postulated
by M. L. Klein et al. (1998), or 1p21-p13, as suggested
by Allikmets et al. (1997), and we conclude that a gene
in either region would have to have a very small effect
on ARM susceptibility, when compared to the regions
on chromosomes 3, 5, 12, and 16. As pointed out by
De La Paz et al. (1999), the difference may be due either
to the way in which the disease was defined in our study,
as opposed to the studies conducted by Allikmets et al.
(1997) or M. L. Klein et al. (1998), or to both the differ-
ence in the population samples being studied and locus
heterogeneity.
A candidate gene for apoptotic protease activating fac-
tor 1 has been mapped to a location slightly upstream
from D12S346 ( ) (see the Ensembl GenomePp .0040
Browser Web site). A precondition for ARM may be an
accumulation of the age pigment lipofuscin in lysosomes
of the RPE cells (Suter et al. 2000). These cells appear
to die by apoptosis, with subsequent death of photore-
ceptor cells. The loss of these cells may result in the more
severe forms of ARM that are expressed by geographic
atrophy and/or exudative detachment of the retina. It has
been suggested that the mitochondria function as cellular
sensors of stress, intowhich different apoptosis-induction
pathways converge (Kroemer and Reed 2000). As the
mitochondria become destabilized, they release apopto-
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sis-inducing proteins such as cytochrome c, which acti-
vates apoptosis-specific proteases called “caspases,” in
addition to apoptosis-inducing factors that induce nu-
clear apoptosis independently of caspase activation (Leist
et al. 1999; Susin et al. 1999; Daugas et al. 2000). Ap-
optotic protease activating factor 1 may be important in
the pathophysiology of cell death related to age-related
macular degeneration and, in the future, for its pharma-
cological control. Other potential candidate genes related
to our chromosome 12 region of interest are given in
table 5.
In summary, our linkage analysis of ARM in the BDES
population appears to provide evidence that markers lo-
cated on chromosome 12 may be linked to ARM. Our
chromosome 12 results are supported by a previous study
of possible linkage between ARM and markers located
in a similar region (Weeks et al. 2000). Furthermore, be-
cause we observed a weak signal on chromosome 1, we
were unable to exclude either candidate-gene region on
chromosome 1, but we conclude that these regions do
not have a major effect on ARM pathogenesis in the
Beaver Dam population.
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